Nano-X Imaging director buys 33,000 shares

Nano-X Imaging Ltd. director Kainan Noga purchased 33,000 ordinary shares on July 28, 2026 at $0.9000 per share in an open-market or private transaction.

Rhea-AI Filing Summary

Nano-X Imaging Ltd. director Kainan Noga purchased 33,000 ordinary shares on July 28, 2026 at $0.9000 per share in an open-market or private transaction. He also reports existing stock options over 12,505, 50,000 and 10,000 shares at exercise prices of $64.6100, $17.6300 and $11.5200, plus 794 ordinary shares held indirectly through I.B.L. Business Consulting Ltd. Additional ordinary shares are reported as underlying restricted share units granted December 10, 2025 that vest in twelve equal monthly installments.

Insider Trade Summary

Net Buyer: 33,000 shares

Net Buy 6 txns

Insider Kainan Noga

Role Director

Bought 33,000 shs ($30K)

Type	Security	Shares	Price	Value
Purchase	Ordinary Shares	33,000	$0.90	$30K
holding	Stock Option (right to buy ordinary shares) F1, F3	--	--	--
holding	Stock Option (right to buy ordinary shares) F1, F4	--	--	--
holding	Stock Option (right to buy ordinary shares) F1, F5	--	--	--
holding	Ordinary Shares F1	--	--	--
holding	Ordinary Shares F1, F2	--	--	--

Holdings After Transaction: Ordinary Shares — 58,336 shares (Direct); Stock Option (right to buy ordinary shares) — 72,505 contracts (Direct); Ordinary Shares — 794 shares (Indirect, By: I.B.L. Business Consulting Ltd, a company wholly owned by the reporting person)

Footnotes (5)

1. F1. There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
2. F2. The ordinary shares reported in this row consist of shares underlying restricted share units that were granted to the Reporting Person on December 10, 2025 and that vest in twelve equal monthly installments such that they will be fully vested upon the one-year anniversary of the grant date.
3. F3. The options reported in this row were granted to the Reporting Person by the Issuer on February 9, 2021 and are fully vested and exercisable as of the date of this report.
4. F4. The options reported in this row were granted to the Reporting Person by the Issuer on December 28, 2022 and are fully vested and exercisable as of the date of this report.
5. F5. The options reported in this row were granted to the Reporting Person by the Issuer on December 31, 2023 and vest and become exercisable in 16 equal installments of 6.25% each on each three-month anniversary of the date of approval of the grant by the Issuer's Board of Directors (i.e., August 14, 2023), such that all options reported in this row will be exercisable on the four-year anniversary of that grant approval date (August 14, 2027).

Key Figures

Shares purchased: 33,000 shares Purchase price: $0.9000 per share Option exercise price: $64.6100 +3 more

6 metrics

Shares purchased 33,000 shares Ordinary shares bought by director on July 28, 2026

Purchase price $0.9000 per share Price for 33,000 ordinary shares acquired

Option exercise price $64.6100 Exercise price for options over 12,505 ordinary shares expiring February 9, 2031

Option exercise price $17.6300 Exercise price for options over 50,000 ordinary shares expiring December 28, 2032

Option exercise price $11.5200 Exercise price for options over 10,000 ordinary shares expiring December 31, 2033

Indirectly held shares 794 shares Ordinary shares held via I.B.L. Business Consulting Ltd.

Key Terms

Stock Option (right to buy ordinary shares), restricted share units, fully vested and exercisable, indirect ownership

4 terms

Stock Option (right to buy ordinary shares) financial

"Security title shows Stock Option (right to buy ordinary shares) with exercise prices"

restricted share units financial

"Ordinary shares reported consist of shares underlying restricted share units granted December 10, 2025"

Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.

fully vested and exercisable financial

"Options were granted and are fully vested and exercisable as of the date of this report"

indirect ownership financial

"Ordinary shares held indirectly by I.B.L. Business Consulting Ltd, wholly owned by the reporting person"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider share transaction did Nano-X Imaging (NNOX) report for Kainan Noga?

Nano-X Imaging reported that director Kainan Noga purchased 33,000 ordinary shares on July 28, 2026. The transaction is classified as a direct open-market or private purchase at $0.9000 per share, with no corresponding sales reported in this disclosure.

How many Nano-X Imaging (NNOX) shares did Kainan Noga buy and at what price?

Kainan Noga bought 33,000 ordinary shares of Nano-X Imaging at a price of $0.9000 per share. The purchase date was July 28, 2026, and it is reported as an open-market or private transaction coded as a purchase of non-derivative securities.

What stock options in Nano-X Imaging (NNOX) does Kainan Noga report holding?

He reports stock options over 12,505 shares at $64.6100 expiring February 9, 2031, 50,000 shares at $17.6300 expiring December 28, 2032, and 10,000 shares at $11.5200 expiring December 31, 2033, all referencing ordinary shares as the underlying security.

What restricted share unit (RSU) holdings are disclosed for Nano-X Imaging (NNOX) director Kainan Noga?

The report states that certain ordinary shares consist of shares underlying restricted share units granted on December 10, 2025. These RSUs vest in twelve equal monthly installments, becoming fully vested on the one-year anniversary of the grant date, adding time-based equity compensation.

Does Kainan Noga have any indirect ownership of Nano-X Imaging (NNOX) shares?

Yes. He is reported as indirectly owning 794 ordinary shares through I.B.L. Business Consulting Ltd, a company wholly owned by him. This indirect position is in addition to his directly held shares and option-based interests in Nano-X Imaging.

Was the Nano-X Imaging (NNOX) insider share purchase made under a Rule 10b5-1 trading plan?

The report indicates the Rule 10b5-1 trading plan checkbox was not affirmed for this transaction. That means the disclosed 33,000-share purchase is not reported as having been executed under a pre-arranged Rule 10b5-1 trading plan framework.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/29/2026 - 07:36 AM Accepted by SEC EDGAR 07/29/2026 - 07:35 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kainan Noga

(Last) (First) (Middle)

C/O NANO-X IMAGING LTD., OFER TECH PARK

94 SHLOMO SHMELTZER ROAD

(Street)

PETACH TIKVA 4970602

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
Nano-X Imaging Ltd. [ NNOX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	07/28/2026		P		33,000	A	$0.9	40,792	D
Ordinary Shares(1)								794	I	By: I.B.L. Business Consulting Ltd, a company wholly owned by the reporting person
Ordinary Shares(1)								17,544(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy ordinary shares)(1)	$64.61							(3)	02/09/2031	Ordinary Shares	12,505		12,505	D
Stock Option (right to buy ordinary shares)(1)	$17.63							(4)	12/28/2032	Ordinary Shares	50,000		50,000	D
Stock Option (right to buy ordinary shares)(1)	$11.52							(5)	12/31/2033	Ordinary Shares	10,000		10,000	D

Explanation of Responses:

1. There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.

2. The ordinary shares reported in this row consist of shares underlying restricted share units that were granted to the Reporting Person on December 10, 2025 and that vest in twelve equal monthly installments such that they will be fully vested upon the one-year anniversary of the grant date.

3. The options reported in this row were granted to the Reporting Person by the Issuer on February 9, 2021 and are fully vested and exercisable as of the date of this report.

4. The options reported in this row were granted to the Reporting Person by the Issuer on December 28, 2022 and are fully vested and exercisable as of the date of this report.

5. The options reported in this row were granted to the Reporting Person by the Issuer on December 31, 2023 and vest and become exercisable in 16 equal installments of 6.25% each on each three-month anniversary of the date of approval of the grant by the Issuer's Board of Directors (i.e., August 14, 2023), such that all options reported in this row will be exercisable on the four-year anniversary of that grant approval date (August 14, 2027).

Remarks:

Exhibit 24.1 - Power of Attorney

	/s/ Marina Gofman Feler, attorney-in-fact	07/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)